Inguinal hernia. Bilateral inguinal hernia, with obstruction, without gangrene
Conditions
Interventions
Intervention 1: In the intervention group after inguinal hernia surgery by Lichtain eshtain methods, 2mg/kg Maracin solusion 0.125 into wound injected. Intervention 2: In control group after inguinal
Treatment - Drugs
In the intervention group after inguinal hernia surgery by Lichtain eshtain methods, 2mg/kg Maracin solusion 0.125 into wound injected
In control group after inguinal hernia surgery by Lichtain eshtain methodsis, 500 mg Naproxen suppository ( 2 suppository 250 mg) was used.
Sponsors
Vice chancellor for research ; Shahroud University of Medical sciences and health
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: Inclusion criteria: All of the patients who scheduled for surgery, inguinal hernia, giving the consent form of participating in the research and had not clinical problems of anesthesia. Exclusion criteria: no consent form to participate in the research, clinical contraindication for anesthesia,clinical problems such as EF <20%, previous history of taking non-steroidal analgesics except aspirin, history of taking proton pump inhibitors, previous history of stomach ulcers and sensitivity to non-steroidal analgesics.
Exclusion criteria
Exclusion criteria:
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Pain evaluation of inguinal hernia ripare. Timepoint: First and sixty hours after surgery and the first and second days after surgery. Method of measurement: Examination and history with VAS system. | — |
Secondary
| Measure | Time frame |
|---|---|
| Satisfaction evaluation. Timepoint: one ; two and three weeks after operation. Method of measurement: Examination and history. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactDr.Mohammad Bagher Sohrabi
Shahroud University of Medical Sciences and Health
Outcome results
None listed